Sbobet sports betting and online football betting on the number 1 website SBOTOP
SBOTOP, the premier destination for online...
Plasmapheresis Market to be Worth $2.55 Billion by 2030
Meticulous Research®—a leading global market research company, published a research report titled, ‘Plasmapheresis Market by Product (Instruments, Disposables), Technology (Membrane Filtration, Centrifugation), Application (Therapeutic [Immunology, Neurology, Hematology], Plasma Collection), End User (Biopharma, Hospitals) - Global Forecast to 2030.’Download Free sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=3092?utm_source=artical&utm_medium=social+&utm_campaign=product&utm_content=15-01-2024
According to this latest publication from Meticulous Research®, the plasmapheresis market is projected to reach $2.55 billion by 2030, at a CAGR of 8.6% from 2023 to 2030. The growth of this market is driven by the rising incidence of autoimmune diseases, increasing demand for source plasma from biopharmaceutical companies, and favorable reimbursement policies for plasmapheresis procedures. In addition, the rising demand for plasmapheresis from emerging countries is expected to provide significant growth opportunities for this market.
However, the high cost of plasmapheresis devices & procedures and the risks associated with plasmapheresis procedures are expected to hinder the growth of this market to a certain extent. In addition, factors such as lack of awareness about plasmapheresis procedures and limited access and availability in certain regions are the major challenges to market growth.
Plasmapheresis Market: Future Outlook
The plasmapheresis market is segmented by product, technology, application, end user, and geography. The study also evaluates industry competitors and analyzes the country and regional-level markets.
Based on product, in 2023, the disposables segment is expected to account for the largest share of the plasmapheresis market. The large market share of this segment is attributed to the recurring utilization of the plasma separation filters and administration sets for the plasmapheresis procedures.
Based on technology, in 2023, the centrifugation segment is expected to account for the largest share of the plasmapheresis market. The large market share of this segment is attributed to the efficient separation of the plasma from other blood components in a short time with the help of technology.
Based on application, in 2023, the source plasma collection segment is expected to account for the largest share of the plasmapheresis market. The large market share of this segment is attributed to the increased demand for source plasma from the pharmaceutical and biotechnology companies, increased demand for plasma proteins and increased awareness about voluntary plasma donations.
Speak to analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=3092?utm_source=artical&utm_medium=social+&utm_campaign=product&utm_content=15-01-2024
Based on end user, in 2023, the source plasma collection segment is expected to account for the largest share of the plasmapheresis market. The large market share of this segment is attributed to the growing demand for source plasma for manufacturing plasma-derived products using plasma fractionation methods.
Geographic Review
This research report analyzes the market across major regions and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa.
In 2023, North America is expected to account for the largest share of the plasmapheresis market, followed by Europe and Asia-Pacific. North America’s major market share is attributed to high awareness about therapeutic applications of plasmapheresis, high prevalence of autoimmune diseases, greater adoption of advanced technologies, and well-established healthcare infrastructure.
Key Players
The key players operating in the plasmapheresis market are Asahi Kasei Corporation (Japan), Terumo Corporation (Japan), Baxter International Inc. (U.S.), B. Braun Melsungen AG (Germany), SB-Kawasumi Laboratories, Inc (Japan), Kaneka Corporation (Japan), Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Shanghai Dahua Medical Apparatus Co., Ltd. (China), and Infomed SA (Switzerland).
Quick Buy: https://www.meticulousresearch.com/Checkout/79432394?utm_source=artical&utm_medium=social+&utm_campaign=product&utm_content=15-01-2024
Key questions answered in the report:
- Which are the high-growth market segments in terms of product, technology, applications, end user, and region/country?
- What was the historical market size for plasmapheresis across the globe?
- What are the market forecasts and estimates for the period 2023–2030?
- What are the major drivers, restraints, opportunities, and challenges in the global plasmapheresis market?
- Who are the major players in the plasmapheresis market?
- How is the competitive landscape, and who are the market leaders in the global plasmapheresis market?
- What are the recent developments in the global plasmapheresis market?
- What are the different strategies adopted by the major players in the global plasmapheresis market?
- What are the geographical trends and high-growth regions/countries?
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Please login to comment on this Post